ASIX · AdvanSix Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 7, 2026TL;DR. AdvanSix's Q2 results showed 3% sales growth to $421 million, but adjusted EPS fell 85% to $0.19 and adjusted EBITDA dropped 43% to $31.9 million on weaker plant nutrients volumes; management guided to second-half sequential improvement supported by lower CapEx, a $0.16 dividend, and progress on the DEF project and USDA FIELDS grant application for ammonia capacity expansion.
- + CapEx guidance of $75–$95 million in 2026, down from $116 million in 2025, supports second-half free cash flow improvement.
- + Full-year 2026 ammonia sales volume expected up 30% versus the prior record year 2025.
- + Targeting approximately $10 million savings exiting 2026 from the multi-year non-manpower fixed cost reduction program.
- − Q2 adjusted EPS of $0.19 was down 85% year-over-year and adjusted EBITDA fell 43% to $31.9 million on lower plant nutrients volumes.
- − Plant Nutrients sales fell 16% year-over-year to $131.4 million as weaker farmer economics reduced in-season fertilizer purchases.
- − Q2 2026 plant turnaround pre-tax impact of ~$10 million and full-year turnaround impact now expected at ~$17 million vs. previously expected to be lower.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASIX
this stock
AdvanSix Inc.
|
$448.22M | -4.0% | +45.5% | — | 2.3% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$65.83B | +13.3% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$20.92B | +24.2% | -7.0% | — | 5.1% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$15.11B | +18.0% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.06B | +9.0% | -7.1% | — | 5.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASIX | -3.5% | +0.4% | -18.0% | -1.3% | -4.1% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -2.3% | +2.2% | -35.9% | -0.9% | -16.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.